Cancer Genome Atlas Reveals Similarities Between Certain Breast and Ovarian Cancers
USPSTF Delivers “D” Recommendation For Ovarian Cancer Screening
Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival
Immunotherapy Demonstrates Disease Control in Phase II Study
Finasteride Does Not Affect Quality of Life, Says Study
Women With Least Aggressive Subtype of Breast Cancer Still at Risk After 10 Years
Study: Lack of Sleep Linked With Agressive Breast Cancers
HPV Can Affect Response To Radiation Therapies
Researchers Find 16 Gene Variants Linked to Colorectal Cancer Using CRCgene Database
NCI-Approved CTEP Trials For the Month of September
FDA Approves Imaging Agent For Recurrent Prostate Cancer
Trending Stories
- Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.” - Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Cancer Center at Illinois is recognized as NCI Basic Cancer Center, becoming the first new institution to earn this designation in 40 years
- Most Favored Nation drug pricing could put China on top
- NCI Director Letai wants you to know: Grant money is flowing again post-government shutdown
- Self-collection kits for HPV are among innovations adding momentum to eradication of cervical cancer
A kit for at-home unsupervised self-collection clears FDA finish line
